FDA Updates 1997 Guidance on CMC Changes for Approved Biologics

Drug Industry Daily
A A
The FDA is revising its 20-year-old guidance on the appropriate categorization of changes in chemistry, manufacturing and controls information in approved BLAs, based on a tiered reporting system.

To View This Article:

Login

Subscribe To Drug Industry Daily